PrehabPal for Malignant Neoplasm of Colon

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
MD Anderson Cancer Center, Houston, TX
Malignant Neoplasm of Colon+1 More
PrehabPal - Behavioral
Eligibility
65+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is studying whether a web app can help older adults prepare for surgery better than written instructions. PrehabPal is a treatment for Malignant Neoplasm of the colon that has been approved by the FDA for a different condition. The treatment can be done online, and no patients in this trial will receive a placebo.

Eligible Conditions

  • Malignant Neoplasm of Colon

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Malignant Neoplasm of Colon

Study Objectives

1 Primary · 4 Secondary · Reporting Duration: 30 days following surgery

30 days following surgery
Proportion of participants with reported Surgical Complications
Readmission Rate
8 weeks post-surgery
Median Satisfaction Scores
Day 2
Median Length of Stay (LOS)
Up to 14 days
Proportion of days before surgery engaged in prehabilitation
Up to 8 weeks
Change in Mean score on the SF-36

Trial Safety

Safety Progress

1 of 3

Other trials for Malignant Neoplasm of Colon

Trial Design

2 Treatment Groups

Written Surgery Prehabilitation Instructions
1 of 2
PrehabPal Web app
1 of 2
Active Control
Experimental Treatment

120 Total Participants · 2 Treatment Groups

Primary Treatment: PrehabPal · No Placebo Group · N/A

PrehabPal Web app
Behavioral
Experimental Group · 1 Intervention: PrehabPal · Intervention Types: Behavioral
Written Surgery Prehabilitation InstructionsNoIntervention Group · 1 Intervention: Written Surgery Prehabilitation Instructions · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 30 days following surgery
Closest Location: MD Anderson Cancer Center · Houston, TX
Photo of MD Anderson Cancer Center 1Photo of MD Anderson Cancer Center 2Photo of MD Anderson Cancer Center 3
2004First Recorded Clinical Trial
5 TrialsResearching Malignant Neoplasm of Colon
528 CompletedClinical Trials

Who is running the clinical trial?

Emerson CollectiveUNKNOWN
1 Previous Clinical Trials
10 Total Patients Enrolled
University of California, San FranciscoLead Sponsor
2,246 Previous Clinical Trials
11,473,020 Total Patients Enrolled
5 Trials studying Malignant Neoplasm of Colon
257 Patients Enrolled for Malignant Neoplasm of Colon
Emily Finlayson, MD, MS, FACSPrincipal InvestigatorUniversity of California, San Francisco

Eligibility Criteria

Age 65+ · All Participants · 6 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have colorectal cancer or unresectable neoplastic polyp.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.